CAR TCR Summit 2021

Optimizing Efficiency in Trial Sponsor and Clinician Relationships

• Sharing perspectives on working with trial sponsors and clinics, logistical challenges, and areas of unmet need
• Comparing experience with CAR and TCR, allogeneic and autologous constructs, their relative challenges, and clinician preferences
• Strategizing to improve patient and investigator access and enrolment, and long-term follow up

Panelists:

Barb Geiger, SVP Clinical Operations, Mana Therapeutics

Allison Matthews, Design Researcher, Mayo Clinic

Joseph McGuirk, Director of HMCT, University of Kansas Cancer Center

Moderator:

Patrick Melvin, Vice President, Novel and Emerging Therapies, TA Lead, Hematology/Oncology, Syneos Health
 

Register Now